Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost–benefit and quality of life analysis
| Title: | Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost–benefit and quality of life analysis |
|---|---|
| Authors: | Lee, Sophie; Knox, Angela; Zeng; Coomarasamy, Christin; Blacklock, Hilary; Issa, Samar |
| Source: | Supportive Care in Cancer. March 2013 21(3):841-846 |
| Database: | Springer Nature Journals |